Physician profile
Mark K Dodson
NPI 1275570467
$7,404.08
in general payments reported to CMS, 2019-2025
5 companies · $74.82 in 2025
The $74.82 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,030 · 2020: $132 · 2021: $144 · 2024: $23.09 · 2025: $74.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.66 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.66 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biom'Up Sa | $6,959.42 | 2019 | |
| Boston Scientific Corporation | $346.75 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $43.25 | 2025 | Enhertu |
| Actelion Pharmaceuticals US, INC. | $31.57 | 2025 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $23.09 | 2024 | Keytruda, Welireg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dodson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.